Heading 4
Heading 4
Heading 4
Heading 4
Heading 4
Heading 4
Heading 4
Heading 4
Heading 4
Heading 4
Heading 4
Heading 4
Hepcinat Plus Tablet
Manufacturer/Marketed By : MYLAN PHARMACEUTICALS PVT LTD
$174.20 $73.16
Hepcinat plus tablet contains active agents Daclatasvir and Sofosbuvir. It is an Anti-Viral medication used to treat chronic hepatitis C virus (HCV) infections. Hepatitis C infection is a liver disease...
Collapsible text is perfect for longer content like paragraphs and descriptions. It's a great way to give people more information while keeping your layout clean. Link your text to anything, including an external website or a different page. You can set your text box to expand and collapse when people click, so they can read more or less info.
SOFOSBUVIR,DACLASTAVIR
Active Pharmaceutical Ingredient
Hepcinat Plus Tablet
174,20$
73,16$
Hepcinat plus tablet contains active agents Daclatasvir and Sofosbuvir. It is an Anti-Viral medication used to treat chronic hepatitis C virus (HCV) infections. Hepatitis C infection is a liver disease caused by the hepatitis C virus (HCV). Talk to your doctor if you have liver problems other than hepatitis C infection, had a liver transplant, diabetes, heart disorders, severe kidney problems, or are on dialysis before taking Hepcinat plus tablet. Your physician will perform blood tests to check for hepatitis B virus infection before starting treatment with this medicine, as this medicine can reactivate the hepatitis B virus. Hepatitis B virus reactivation can cause serious liver problems and liver failure. It is vital to inform your doctor if you are taking or have taken any medication for heart problems in the past months. Elderly patients may be more susceptible to the side effects of Hepcinat plus tablet and may require lower doses or closer monitoring during treatment. The safety and effectiveness of pediatric patients have not been established. These medications should only be used in children under the guidance of a pediatric specialist.
Active Pharmaceutical Ingredient
Uses
• Treatment of chronic hepatitis C virus (HCV) infection
Benefits
Daclatasvir is a direct-acting antiviral medication that works by inhibiting a protein called NS5A, which is essential for the replication of the hepatitis C virus. Sofosbuvir is another direct-acting antiviral medication that works by inhibiting a different protein called NS5B, which is also essential for the replication of the hepatitis C virus. These are used to increase its effectiveness in treating HCV.
Side Effects
Hepcinat plus tablet cause some side effects like all medications, although not everyone will experience them.
Most Common Side Effects
• Headache
• Fatigue
• Nausea
• Diarrhea
• Difficulty sleeping
Common Side Effects
• Liver problems (such as elevated liver enzymes or liver failure)
• Allergic reactions (such as rash or difficulty breathing)
• Abnormal heart rhythms
How To Use
Take Hepcinat plus tablet exactly as prescribed by your doctor. The recommended dose and dosing schedule may vary depending on your medical condition, age, weight, and other factors. It should be taken with food. Swallow the tablet as a whole with a glass of water. Patients should not chew, crush, or break the tablet, as this may affect the effectiveness of the medication. Avoid doubling the dose to compensate for the missed dose.
Safety Advice
• Breast Feeding: It is unknown if Hepcinat plus tablet is excreted in human breast milk, so breastfeeding women should consult a healthcare provider before taking this medication.
• Alcohol: Drinking alcohol while taking Hepcinat plus tablet is generally not recommended. Alcohol can have negative effects on the liver, which can exacerbate the effects of hepatitis C.
• Liver: Hepcinat plus tablets are primarily used to treat hepatitis C. Patients having other liver ideas should consult a doctor before taking them.
• Lungs: Patients should consult a healthcare provider with any pre-existing lung conditions with their healthcare provider before starting treatment with Hepcinat plus tablet.
• Driving: Patients should always monitor their response to the Hepcinat plus tablet medication and be cautious when driving or operating machinery if they experience any side effects that may impair their ability to do so safely.
• Pregnancy: The safety of Hepcinat plus tablet during pregnancy is not well-established. Pregnant women should consult their healthcare provider about their pregnancy status before receiving this medication.
Disclaimer
Sidmex Inovia strives to provide accurate and reliable information; however, all content on this website, including product descriptions and compositions, is for informational purposes only and should not be considered a substitute for professional medical advice, diagnosis, or treatment.
Users are advised to consult a qualified healthcare professional before making any medical decisions. The information provided should not be used for self-diagnosis or self-medication.
All products listed are intended strictly for B2B and bulk inquiry purposes only. Sidmex Inovia does not promote direct consumer use and aims to support, not replace, the healthcare professional–patient relationship.
Product names, trademarks, and brands belong to their respective owners, and their use does not imply any affiliation or endorsement. Sidmex Inovia shall not be held responsible for any consequences arising from the use of the information provided on this website.